Utility of T-cell immunosequencing in distinguishing mycosis fungoides progression from treatment related cutaneous adverse events

Cutaneous adverse events of both topical and systemic drugs in patients with mycosis fungoides (MF) present a diagnostic challenge as it is often difficult PROBIOTIC GUM to distinguish drug associated rash from disease progression in the skin.Mogamulizumab and mechlorethamine gel are approved treatments for MF, both of which can cause treatment rel

read more